Prevalence and clinical implications of atrial fibrillation in patients hospitalized due to COVID-19: Data from a registry in Poland.
Frontiers in cardiovascular medicine(2023)
摘要
AF increases short- and long-term risk of death in patients hospitalized due to COVID-19. However, the use of NOACs in this group may profoundly improve prognosis.
更多查看译文
关键词
COVID-19,MACE,NOAC drugs,anticoagulation,atrial fibrillation,prognosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要